Oxy210, a novel inhibitor of hedgehog and TGF‐β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice is a research paper published in Endocrinology Diabetes & Metabolism (2021). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: HL147883
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: DK117850
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: DK120342
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: DK125139
NIDDK NIH HHS
Grant: R43 DK125139
NIDDK NIH HHS
Grant: R01 DK117850
NHLBI NIH HHS
Grant: R01 HL147883
NIDDK NIH HHS
Grant: U54 DK120342
National Institutes of Health
Grant: 1R01DK117850-01A1
Systems genetics dissection of non-alcoholic steatohepatitis
National Institutes of Health
Grant: 1R43DK125139-01A1
Inhibition of Liver Fibrosis by Oxysterol Drug Candidates in a Mouse Model of NASH
National Institutes of Health
Grant: 5U54DK120342-03
Sex Differences in the Metabolic Syndrome
National Institutes of Health
Grant: 5R01HL147883-02
Systems genetics approach to inflammatory mechanisms in atherosclerosis
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Oxysterol derivatives Oxy186 and Oxy210 inhibit WNT signaling in non-small cell lung cancer
Additional file 1 of Oxysterol derivatives Oxy186 and Oxy210 inhibit WNT signaling in non-small cell lung cancer